Heart attacks, heart failure and strokes were reduced by almost a third in a cohort of over-50 adults, and deaths decreased in this group by almost a quarter, compared to the target systolic pressure of 140mm Hg.

Participants in the SPRINT study had to fit a particular health and age profile. In addition to all SPRINT subjects being over age 50, the trial only enrolled subjects if they had an elevated blood pressure and increased cardiovascular risk. So, is the SPRINT study exactly analogous to us? Does it have direct and parallel utility for healthy triathletes? We'll explore the relevance of this study's findings for us.